Source: DEVICESPACE

Valence Advantage Life Sciences Fund: San Francisco Based-Invuity, Inc. Raises $36 Million In Series E Funding

/www.biospace.com/enewsletter.aspx?typeseo-article&sourcenews-signup" ALT"free biotech news">/enewsletters.biospace.com/images/news/cta-latest-biotech-news.jpg" ALIGN"bottom" USEMAP"#cta-BiotechNews" border"0" alt"Get the latest biotech news where you want it. Sign up for the...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

Founder & CEO

Rachel Leheny

CEO Approval Rating

69/100

Read more